Comments for: Diabetes drug poses high risk, report says

Diabetes drug poses high risk, report says
WASHINGTON – A diabetes medicine poised to win Food and Drug Administration approval sharply increases the risk of heart problems, strokes and death, researchers reported Thursday in an analysis that raises pointed new questions about the agency’s handling of drug safety issues. The drug, Pargluva,… Read More
      Read more

      You may also like

      By continuing to use this site, you give your consent to our use of cookies for analytics, personalization and ads. Learn more.